TETANUS AND BOTULINUM
NEUROTOXINS AND NEURONAL CELL BIOLOGY
|
|||
Elaine
A. Neale, Ph.D., Principal Investigator |
![]() |
||
Research
in the Section on Cell Biology, directed by Elaine Neale, use biochemical
and morphologic techniques to focus on synaptic function in primary neuronal
cell cultures. In particular, studies use the clostridial neurotoxins (tetanus
and botulinum), which block vesicular neurotransmitter release by cleaving
specific proteins implicated in synaptic vesicle fusion with the presynaptic
membrane. The identity of toxin receptor(s), the organelles involved in
toxin uptake, the mechanism of toxin translocation into the neuronal cytoplasm,
and intracellular trafficking of the toxins are subjects of active research.
These toxins are important therapeutic agents for a number of neurologic
disorders, including cerebral palsy, and are valuable tools for understanding
neurotransmitter release, membrane trafficking, and protein sorting, transport,
and targeting. Botulinum toxin remains a public health problem and an agent
of bioterrorism; a more complete understanding of its intracellular functioning
will aid in designing an appropriate therapy. Uncertainly persists as to whether gangliosides, which are abundant on the neuronal surface membrane and bind tetanus and botulinum neurotoxins with a relatively low affinity, do in fact function as productive toxin receptors. We have found that the drug fumonisin B1, which blocks ganglioside synthesis and depletes membranes of gangliosides, protects neurons against the action of tetanus toxin (Williamson et al., J Biol Chem 274:25173, 1999) and botulinum neurotoxin A (BoNT A). Figure 19 Potassium-evoked glycine release is inhibited by 40 percent in cultures exposed to BoNT A under the conditions of this experiment. Sister cultures maintained in the drug fumonisin B1 are ganglioside-depleted and are almost totally protected from the effects of BoNT A on glycine release. C; control; B; BoNT A; F; fumonisin; F+B; fumonisin + BoNT A. In both cases, the addition of exogenous gangliosides to ganglioside-depleted neurons restores toxin action. In this regard, GQ1b and GT1b are approximately equivalent while GD1b is less effective in restoring the action of BoNT A. High concentrations of gangliosides enhance toxin effect even beyond that in control cultures. These findings indicate that neuronal membrane gangliosides are a critical component of the receptor required for delivery of BoNT A to the neuronal cytosol. Figure 20 Sequential additions of BoNT A and E to demonstrate
persistent action of BoNT A. Cultures were exposed to 0.4 pM BoNT A for
72 hours. Of the three bands labeled SNAP-25, the highest kDa represents
intact SNAP-25; the next lower, BoNT A-cleaved SNAP-25 (missing nine amino
acids from the C-terminus); and the lowest, BoNT E-cleaved SNAP25 (missing
26 amino acids from the C-terminus). Lane 1 shows that about half of SNAP-25
is cleaved 25 days after BoNT A exposure when cultures were exposed to
250 pM BoNT E for 24 hours. Both intact and BoNT A-truncated SNAP-25 were
converted into the BoNT E-altered form (lane 2). During the ensuing 18
days, increases were observed in intact and BoNT A-truncated SNAP-25 while
the BoNT E-truncated SNAP-25 gradually disappeared (lanes 3 through 6).
(From Keller et al. FEBS Lett 1999;456:137) Figure 21 BoNT A effects on neurotransmitter release and SNAP-25 cleavage. Potassium-evoked glycine release was measured with 0.15 (squares), 0.25 (triangles), or 2 mM (circles) Ca2+. Level of SNAP-25 cleavage as determined by densitometric analysis of Western blots is also plotted (diamonds). (From Keller and Neale, J Biol Chem 2001;276:13476) We had shown that blockade of neurotransmitter release by TeNT or BoNT A is correlated with increased numbers of synaptic vesicles jammed up at the presynaptic membrane, consistent with toxin damage to proteins required for vesicle fusion and neurotransmitter release. However, in cultures treated with concentrations of BoNT A sufficient to block vesicle exocytosis, K+ stimulation in the presence of Ca2+ induced synaptic vesicle endocytosis, suggesting that BoNT A can uncouple components of the recycling mechanism. Current studies using fluorescence and electron microscopy are aimed at defining the relationship, in individual synaptic terminals, between synaptic vesicle exo- and endocytosis, particularly as modified by BoNT A. Figure 22 Endocytosis of horseradish peroxidase by K+ depolarization. a. Control. Recycled synaptic vesicles contain peroxidase reaction product. b.. TeNT. Only occasional synaptic vesicles contain reaction product, indicating the failure of synaptic vesicles to undergo recycling. c. BoNT A. A large number of synaptic vesicles contain reaction product, evidence that the vesicles were formed from surface membrane. Insets. Reaction product labeling of clathrin-coated vesicles implicates these structures in the process of vesicle recycling. (From Neale et al. J Cell Biol 1999;147:1249) |
|||
PUBLICATIONS
|
|||